MedTrace Logo

Determination of Diastolic Dysfunction by Single Lead Electrocardiogram

NCT04474639 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2021-08-31

No results posted yet for this study

Summary

It is a prospective, controlled, single-center, non-randomized, observational study.

From September 2019 to December 2020, the study plans to prospectively include 400 patients aged 18 to 90 years.

Every patients will undergo an echocardiographic examination with assessment diastolic dysfunction of the left ventricle, and registration of an electrocardiogram using a single lead ECG monitor CardioQvark (in I standard lead) for 3 minutes. All patients will be divided into 2 main groups: with diastolic dysfunction of the left ventricle, confirmed by the results of the echocardiography and without. A spectral analysis of the electrocardiogram will be performed using a continuous wavelet transform.

The result of this study will be the identification of ECG parameters that will correlate with LV diastolic dysfunction.

Conditions

  • Diastolic Function

Interventions

DEVICE

echocardiographic examination

conducting an echocardiographic study according to a standard protocol with the determination of diastolic dysfunction of the left ventricle

Sponsors & Collaborators

  • I.M. Sechenov First Moscow State Medical University

    lead OTHER

Principal Investigators

  • Philipp Kopylov · I.M. Sechenov First Moscow State Medical University (Sechenov University)

  • Natalia Kuznetsova · I.M. Sechenov First Moscow State Medical University (Sechenov University)

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-09-01
Primary Completion
2021-06-30
Completion
2021-08-29

Countries

  • Russia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04474639 on ClinicalTrials.gov